WASHINGTON, April 26 (Reuters) - A cooperation between the
United States and three of its closest Indo-Pacific partners to
supply up to a billion coronavirus vaccine doses across Asia by
the end of 2022 was 'still on track', senior administration
officials said on Monday, despite a surge of the virus in India,
one of the countries involved.
"It's moving forward expeditiously," a senior administration
official told reporters in a briefing call. In March, a Quad
fact sheet said the United States, through its International
Development Finance Corp, would work to finance Indian drugmaker
Biological E Ltd to produce at least 1 billion COVID-19 vaccine
doses by the end of 2022.
(Reporting by Andrea Shalal, Allison Martell and Humeyra Pamuk,
Editing by Franklin Paul)